| 1 |
Jonathan W. Hui |
Cisco |
40 |
| 2 |
Ayman Hammad |
Visa |
13 |
| 3 |
Xiangping Qian |
Cytokinetics |
12 |
| #4 |
Andrew Buchanan Gault |
Sony |
9 |
| #4 |
XIN-YUAN WU |
Foxconn |
9 |
| #4 |
Somasekhar Bhamidipati |
Rigel Pharmaceuticals |
9 |
| #4 |
Jiazhong Zhang |
Plexxikon |
9 |
| #8 |
Madhusudan K. Iyengar |
IBM |
8 |
| #8 |
Jongmin Baek |
Samsung |
8 |
| #8 |
David Lowe |
Winview |
8 |
| #11 |
Orit Foord |
AbbVie |
7 |
| #11 |
Junfa Fan |
Chemocentryx |
7 |
| #11 |
Qing Xu |
Global Blood Therapeutics |
7 |
| #11 |
Zice Fu |
Amgen |
7 |
| #11 |
Penglie Zhang |
Chemocentryx |
7 |
| #11 |
Doe Hyun Yoon |
LG |
7 |
| #11 |
Sanjeev Gangwar |
Bristol-Myers Squibb |
7 |
| #18 |
Guoxian Wu |
Plexxikon |
6 |
| #18 |
Michael George Farley |
Tile |
6 |
| #18 |
Fang Wang |
Gilead Pharmasset |
6 |
| #18 |
Yonghong Song |
Portola Pharmaceuticals |
6 |
| #22 |
Victor Octav Suba Miura |
— |
5 |
| #22 |
Yajun Zheng |
Vitae Pharmaceuticals |
5 |
| #22 |
Ernest A. Carra |
Gilead Sciences |
5 |
| #22 |
Gregory Steven Wagner |
Zenith Epigenetics |
5 |
| #22 |
Richard Marks |
Sony |
5 |
| #22 |
Aditya R. Ganjam |
Conviva |
5 |
| #22 |
Eric McCallister Bennett |
Gopro |
5 |
| #22 |
Lan Wang |
Genentech |
5 |
| #22 |
Feng Tian |
Mks Instruments |
5 |
| #22 |
Katsumi Nagata |
Toyota |
5 |
| #22 |
Mark S. Smyth |
Onyx Therapeutics |
5 |
| #22 |
Britton Kenneth Corkey |
Gilead Sciences |
5 |
| #22 |
Xiaodong Mao |
Sony |
5 |
| #35 |
Hui Shao |
AbbVie |
4 |
| #35 |
James F. Kramer |
Groupon |
4 |
| #35 |
Petr Jansa |
Gilead Sciences |
4 |
| #35 |
Yibin Zeng |
Chemocentryx |
4 |
| #35 |
Michael P. Arend |
Fibrogen |
4 |
| #35 |
Nicholas J. Cardell |
Sony |
4 |
| #35 |
Mohamed Soliman |
Halliburton Energy Services |
4 |
| #35 |
Atiyeh Ghoreyshi |
Google |
4 |
| #35 |
Kuan-Chieh Yen |
Dolby Laboratories Licensing |
4 |
| #35 |
Caleb E. Welton |
Emc |
4 |
| #35 |
Dmitry Koltun |
Gilead Sciences |
4 |
| #35 |
Vahid Zia |
Gilead Sciences |
4 |
| #35 |
Reza Oliyai |
Gilead Sciences |
4 |
| #35 |
David Cheung |
Applied Materials |
4 |
| #35 |
Haolun Jin |
Gilead Sciences |
4 |
| #35 |
Utsaw Kumar |
Intel |
4 |